Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of lotilaner ophthalmic solution, 0.25% for the treatment of blepharitis due to demodex infestation: A randomized, controlled, double-masked clinical trial.
Gonzalez-Salinas R, Karpecki P, Yeu E, Holdbrook M, Baba SN, Ceballos JC, Massaro-Corredor M, Corredor-Ortega C, Ramos-Betancourt N, Quiroz-Mercado H. Gonzalez-Salinas R, et al. Among authors: holdbrook m. Cont Lens Anterior Eye. 2022 Aug;45(4):101492. doi: 10.1016/j.clae.2021.101492. Epub 2021 Jul 28. Cont Lens Anterior Eye. 2022. PMID: 34332895 Free article. Clinical Trial.
Treatment of Demodex Blepharitis: A Prospective, Randomized, Controlled, Double-Masked Clinical Trial Comparing Topical Lotilaner Ophthalmic Solution, 0.25% Eyedrops to Vehicle.
Yeu E, Holdbrook M, Baba SN, Ceballos JC, Massaro-Corredor M, Corredor-Ortega C, Ramos-Betancourt N, Quiroz-Mercado H, Gonzalez-Salinas R. Yeu E, et al. Among authors: holdbrook m. Ocul Immunol Inflamm. 2023 Oct;31(8):1653-1661. doi: 10.1080/09273948.2022.2093755. Epub 2022 Aug 1. Ocul Immunol Inflamm. 2023. PMID: 35914297 Free article. Clinical Trial.
Psychosocial Impact of Demodex Blepharitis.
O'Dell L, Dierker DS, Devries DK, Garlich J, Whitley WO, Holdbrook M, Baba SN, Yeu E. O'Dell L, et al. Among authors: holdbrook m. Clin Ophthalmol. 2022 Sep 2;16:2979-2987. doi: 10.2147/OPTH.S374530. eCollection 2022. Clin Ophthalmol. 2022. PMID: 36081601 Free PMC article.
Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis: Randomized, Vehicle-Controlled, Multicenter, Phase 3 Trial (Saturn-2).
Gaddie IB, Donnenfeld ED, Karpecki P, Vollmer P, Berdy GJ, Peterson JD, Simmons B, Edell ARP, Whitson WE, Ciolino JB, Baba SN, Holdbrook M, Trevejo J, Meyer J, Yeu E; Saturn-2 Study Group. Gaddie IB, et al. Among authors: holdbrook m. Ophthalmology. 2023 Oct;130(10):1015-1023. doi: 10.1016/j.ophtha.2023.05.030. Epub 2023 Jun 5. Ophthalmology. 2023. PMID: 37285925 Free article. Clinical Trial.
The impact of Demodex blepharitis on patient symptoms and daily life.
Barnett M, Simmons B, Vollmer P, Patel A, Whitson WE, Berdy GJ, Karpecki P, Periman LM, Holdbrook M, Baba SN, Meyer J, Yeu E. Barnett M, et al. Among authors: holdbrook m. Optom Vis Sci. 2024 Mar 1;101(3):151-156. doi: 10.1097/OPX.0000000000002111. Epub 2024 Feb 7. Optom Vis Sci. 2024. PMID: 38546756 Free PMC article.
22 results